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Table 2
GRACE
Low RDW
(n¼ 129)
High RDW
(n¼64) P
Inhospital mortality 0.013
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Srisk score. In receiver–operating characteristic curve analysis, the RDW value >15.74
yielded an area under the curve value of 0.87, with 64% sensitivity and 65% speciﬁcity.
Conclusion: Our study results demonstrated that, high RDW was an independent
predictor of high GRACE risk score and it was associated with in-hospital cardio-
vascular mortality in UAP/NSTEMI.Table 1
Low RDW group
(n ¼ 129)
High RDW group
(n ¼ 64) P
Age, years 62.6  12.5 65.8  12.8 0.101
Male sex, n (%) 72 (56) 38 (60) 0.554
Previous MI, n (%) 33 (26) 21 (33) 0.262
Diabetes mellitus, n (%) 38 (30) 21 (33) 0.585
Hypertension, n (%) 78 (61) 45 (71) 0.137
Anemia, n (%) 21 (43) 28 (57) <0.001
Current smoker, n (%) 49 (38) 25 (40) 0.820
LVEF % 53.5  8.1 48.4  9.1 <0.001
UAP, n (%) 39 (30) 15 (24) 0.353
NSTEMI, n (%) 89 (69) 48 (76) 0.300
Hemoglobine, g/dl 13.8  1.6 12.6  2.0 <0.001
Hemotocrite % 39.9  4.3 37.3  5.4 0.001
Creatinine mg/dl 0.86  0.4 1.3  1.5 0.022
ASA, n (%) 129 (100) 62 (98) 0.151
Clopidogrel, n (%) 116 (90) 60 (95) 0.420
Beta-blocker, n (%) 127 (98) 62 (98) 0.985
ACEI/ARB, n (%) 124 (96) 53 (84) 0.040
Statins, n (%) 127 (98) 61 (97) 0.459
Baseline Characteristics and Laboratory Findings of the Study Patients
GRACE risk group
Low, n (%) 36 (27.9) 9 (14.5)
Medium, n (%) 50 (38.8) 19 (30.6)
High, n (%) 43 (33.3) 34 (54.8)
Discharge to 6 month mortality 0.045
Low, n (%) 45 (34.9) 13 (20.6)
Medium, n (%) 30 (23.3) 12 (19)
High, n (%) 54 (41.9) 38 (60.3)
GRACE risk scores
Inhospital death, score 124.833.6 148.946.3 <0.001
Inhospital death or MI, score 162.550.6 203.064.3 <0.001
Admission to 6 month death, score 101.428.8 119.937.4 <0.001
Admission to 6 month death or MI,
score
139.240.0 168.851.1 <0.001
Correlations between RDW and GRACE risk groups and GRACE risk score
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Aim: Atrioventricular conduction blocks (AVCB) may occur after inferior wall ST
elevation myocardial infarctions (I-STEMI). AVCB development increases mortality
and morbidity rates. In this study, we aimed to evaluate the importance of clinical
(GRACE) and angiographical (SYNTAX) scores in prediction of AVCB
development.
Methods: 339 patients admitted to our center with I-STEMI between August 2012-
January 2013 were included in the study. The patients with a typical chest pain, having
ST segment elevation of >1mm in 2 inferior leads (DII, DIII, aVF), and elevation in
serum cardiac enzymes (CK-MB and Troponin-I) were deﬁned as I-STEMI. The
patients who had prior myocardial infarction, chronical lung or hepatic pathologies,
with a history of cerebrovascular events and renal failure (cretinine >2.5 mg/dl) were
not accepted in the study. Blood samples were obtained from laboratory results of the
ﬁrst reference period. All the patients were followed by 72 hours period admitted to
our center with event recorder monitors. GRACE scores (GS) of the patients were
calculated when they ﬁrst admitted to the emergency service. SYNTAX score values
were calculated with a computer programme (www.syntaxscore.com) according to the
patients angiographic ﬁndings. The characteristics of AVCB patients were evaluated
with statistical analysis.
Findings: The patients’mean age was 64.212.1 and 260 of them were male. Patients
with AVCB were older, and their heart rate and blood pressure means were lower at
admission. Furthermore, creatinine levels, troponin index (troponin-ı / body surface
area), SS and GS means were higher in AVCB patients. Complications and mortality
rates were higher in AVCB patients (Table 1). Permanenet pacemaker implantation
were performed on eleven patients during our study. According to the ROC and
logistic regression analysis, it was determined that GS predicted AVCB
development better than SS (Figure 1 and Table 2).
Results: High degree of AVCB development after I-STEMI is nearly %15 of all cases.
Event recorder monitoring is the best method to follow the I-STEMI patients in
intensive care units. GS, one of the clinical scoring systems, predicts AVCB devel-
opment better than SS, which is an angiographic scoring system. GS calculation might
be useful in terms of prognasis after I-STEMI.ol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/ORALS
Table 2. Logistic regression analysis.
B S.E. Wald df Sig. Exp(B)
Diabetes Mellitus -,261 ,365 ,509 1 ,476 ,771
No-reﬂow 1,425 ,399 12,732 1 ,000 4,158
Arrest on admission ,670 ,693 ,936 1 ,333 1,954
Tiroﬁban -,602 ,450 1,789 1 ,181 ,548
Drug Eluting Stent -,237 ,429 ,306 1 ,580 ,789
Thrombus Aspiration ,030 ,559 ,003 1 ,957 1,030
Direct Stent -,219 ,401 ,299 1 ,156 ,803
Cardiogenic Shock ,605 ,427 2,012 1 ,216 1,832
Right Coronary Artery ,501 ,405 1,531 1 ,145 1,650
Circumﬂex Artery -,428 ,294 2,126 1 ,039 ,652
SYNTAX Score >22 ,602 ,292 4,255 1 ,039 1,825
GRACE score > 140 ,834 ,297 7,869 1 ,005 2,303
Constant -,662 ,483 1,878 1 ,171 ,516
No-reﬂow phenomenon during primary percutaneous coronary intervention, GRACE score >
140 and SYNTAX score > 22 were the best predictors of atrioventricular conduction block
development.Table 1. General charasteristics of the patients.
AVCB (-) AVCB (+) p value
Age (year) 63.512.3 67.111.4 0.039
Systolic Blood Pressure (mmHg) 131.825.8 101.130.2 <0.001
Diastolic Blood Pressure (mmHg) 80.715.8 61.518.2 <0.001
Troponin Index (Troponin-I/Body
surface area)
32.932.1 43.439.5 0.032
Creatinine (mg/dl) 0.960.64 1.170.62 0.026
GFR(ml/min/1.73 m2) 88.234.7 77.939.0 0.138
Potassium (mEq/L) 4.512.49 4.361.72 0.823
Blood Glucose (mg/dl) 146.965.9 160.494.5 0.050
Ejection Fraction (%) 46.37.2 42.68.9 0.001
Symptom-to-door time (hour) 4.324.0 4.764.57 0.466
Door-to-balloon time (minute) 21.76.1 21.35.9 0.600
Diabetes Mellitus (n¼62) 49 (%17.4) 13 (%22.4) 0.357
Cardiogenic Shock (n¼42) 25 (%8.9) 17 (%29.3) <0.001
Mortality (n¼20) 11 (%3.9) 9 (%15.5) 0.001
Ventricular Arrhythmias (n¼46) 30 (%10.7) 16 (%27.6 0.001
Temporary Pacemaker (n¼23) 12 (%4.3) 11 (%11) <0.001
Permanent Pacemaker (n¼11) 0 11 (%19) 0.001
_Inferior+Right Ventricular STEMI
(n¼172)
134
(%47.7)
38 (%65.5) 0.001
GRACE score in hospital 148.537.8 185.949.7 <0.001
SYNTAX score 20.89.2 22.110.2 0.322
Balloon diameter (mm) 2.110.68 2.120.64 0.892
Stent diameter (mm) 3.020.77 3.140.70 0.345
Stent length (mm) 24.012.4 26.913.8 0.182
Tiroﬁban usage (n¼51) 40 (%14.2) 11 (%19) 0.359
Drug Elauting Stent _Implantation
(n¼46)
42 (%14.9) 4 (%6.9) 0.103
Direct Stenting (n¼53) 45 (%16) 8 (%13.8) 0.672
Thrombus Aspiration (n¼25) 20 (%7.1) 5 (%8.6) 0.690
Coronary blood ﬂow < TIMI III (n¼63) 45 (%16) 18 (%31) 0.007
AVCB; Atrioventricular conduction block, GFR; Glomerular Filtration Rate, STEMI; ST elevation
myocardial infarction.
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Purpose: The Global Registry for Acute Coronary Events (GRACE) and the
Thrombolysis in Myocardial Infarction (TIMI) risk scores predict adverse clinical
outcomes in patients with non-ST elevation acute coronary syndromes (NSTEACS).
In the present study, we sought to determine whether GRACE and TIMI risk scores
correlate with angiographic extent and complexity of coronary artery disease (CAD)
according to SYNTAX score (SXscore) in patients with NSTEACS undergoing
catheterization.
Methods: We performed a retrospective analysis of 167 consecutive NSTEACS
patients (mean age: 5911 years) who underwent coronary angiography and had at
least one signiﬁcant vessel disease (>50% stenosis in a vessel 1.5 mm). SXscore,
a marker of CAD severity, was assessed from angiograms using the SXscore algo-
rithm as described in detail on the SXscore web site. In order to investigate predictive
ability of clinical risk scores in determination of CAD severity, patients were divided
into 3 groups according to their GRACE risk scores: GRACE scores 0 to 108 (low,
n¼68), 109 to 140 (intermediate, n¼51), and >140 (high, n¼48). Similarly, patients
were classiﬁed into 3 categories according to TIMI risk scores: TIMI scores 0 to 2
(low, n¼51), 3 to 4 (intermediate, n¼94), and 5 to 7 (high, n¼21).
Results: The SXscore ranged from 2 to 76 with a mean value of 17.514.0. There
were signiﬁcant correlations between SXscore and GRACE (r¼0.260, p¼0.001) and
TIMI (r¼0.222, p¼0.004) risk scores. There was a signiﬁcant trend for higher
SXscore in higher GRACE and TIMI score groups (Table 1 and 2).
Conclusion: In patients with NSTEACS, both GRACE and TIMI risk scores are
correlated with the extent and severity of CAD. Therefore, in patients with higher
GRACE and TIMI risk scores, CAD can be predicted to be more diffuse and severe.Table 2. SYNTAX score for TIMI risk score categories
Low (0 - 2)
Intermediate
(3 - 4) High (5 - 7) P value
SYNTAX score 13.7  10.9 17.5  13.3 27.2  19.4 0.001
Table 1. SYNTAX score for GRACE risk score categories
Low (0-108)
Intermediate
(109-140) High (>140) P value
SYNTAX score 12.9  10.0 20.1  16.5 21.2  14.5 0.002OP-063
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